These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 2847641)
1. In vitro cleavable-complex assay to monitor antimicrobial potency of quinolones. Walton L; Elwell LP Antimicrob Agents Chemother; 1988 Jul; 32(7):1086-9. PubMed ID: 2847641 [TBL] [Abstract][Full Text] [Related]
2. A comparison of active site binding of 4-quinolones and novel flavone gyrase inhibitors to DNA gyrase. Hilliard JJ; Krause HM; Bernstein JI; Fernandez JA; Nguyen V; Ohemeng KA; Barrett JF Adv Exp Med Biol; 1995; 390():59-69. PubMed ID: 8718602 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of the des-F(6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays. Wu P; Lawrence LE; Denbleyker KL; Barrett JF Antimicrob Agents Chemother; 2001 Dec; 45(12):3660-2. PubMed ID: 11709365 [TBL] [Abstract][Full Text] [Related]
4. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases. Blanche F; Cameron B; Bernard FX; Maton L; Manse B; Ferrero L; Ratet N; Lecoq C; Goniot A; Bisch D; Crouzet J Antimicrob Agents Chemother; 1996 Dec; 40(12):2714-20. PubMed ID: 9124828 [TBL] [Abstract][Full Text] [Related]
5. The phytotoxin albicidin is a novel inhibitor of DNA gyrase. Hashimi SM; Wall MK; Smith AB; Maxwell A; Birch RG Antimicrob Agents Chemother; 2007 Jan; 51(1):181-7. PubMed ID: 17074789 [TBL] [Abstract][Full Text] [Related]
6. Discoordinate gene expression of gyrA and gyrB in response to DNA gyrase inhibition in Escherichia coli. Neumann S; Quiñones A J Basic Microbiol; 1997; 37(1):53-69. PubMed ID: 9090126 [TBL] [Abstract][Full Text] [Related]
7. Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity. Aubry A; Pan XS; Fisher LM; Jarlier V; Cambau E Antimicrob Agents Chemother; 2004 Apr; 48(4):1281-8. PubMed ID: 15047530 [TBL] [Abstract][Full Text] [Related]
8. Characterization of Campylobacter jejuni DNA gyrase as the target of quinolones. Changkwanyeun R; Usui M; Kongsoi S; Yokoyama K; Kim H; Suthienkul O; Changkaew K; Nakajima C; Tamura Y; Suzuki Y J Infect Chemother; 2015 Aug; 21(8):604-9. PubMed ID: 26096494 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of differential activities of ofloxacin enantiomers. Morrissey I; Hoshino K; Sato K; Yoshida A; Hayakawa I; Bures MG; Shen LL Antimicrob Agents Chemother; 1996 Aug; 40(8):1775-84. PubMed ID: 8843280 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of quinolones against Escherichia coli DNA gyrase. Yoshida H; Nakamura M; Bogaki M; Ito H; Kojima T; Hattori H; Nakamura S Antimicrob Agents Chemother; 1993 Apr; 37(4):839-45. PubMed ID: 8388200 [TBL] [Abstract][Full Text] [Related]
12. Inhibition by quinolones of DNA gyrase from Staphylococcus aureus. Tanaka M; Sato K; Kimura Y; Hayakawa I; Osada Y; Nishino T Antimicrob Agents Chemother; 1991 Jul; 35(7):1489-91. PubMed ID: 1656864 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II. Moreau NJ; Robaux H; Baron L; Tabary X Antimicrob Agents Chemother; 1990 Oct; 34(10):1955-60. PubMed ID: 1963290 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of inhibition of DNA gyrase by ES-1273, a novel DNA gyrase inhibitor. Oyamada Y; Yamagishi J; Kihara T; Yoshida H; Wachi M; Ito H Microbiol Immunol; 2007; 51(10):977-84. PubMed ID: 17951987 [TBL] [Abstract][Full Text] [Related]
15. Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis. Revel-Viravau V; Truong QC; Moreau N; Jarlier V; Sougakoff W Antimicrob Agents Chemother; 1996 Sep; 40(9):2054-61. PubMed ID: 8878580 [TBL] [Abstract][Full Text] [Related]
16. Cleavable-complex formation by wild-type and quinolone-resistant Streptococcus pneumoniae type II topoisomerases mediated by gemifloxacin and other fluoroquinolones. Yague G; Morris JE; Pan XS; Gould KA; Fisher LM Antimicrob Agents Chemother; 2002 Feb; 46(2):413-9. PubMed ID: 11796351 [TBL] [Abstract][Full Text] [Related]
17. Effect of pyrimido[1,6-a]benzimidazoles, quinolones, and Ca2+ on the DNA gyrase-mediated cleavage reaction. Gmünder H; Kuratli K; Keck W Antimicrob Agents Chemother; 1995 Jan; 39(1):163-9. PubMed ID: 7695300 [TBL] [Abstract][Full Text] [Related]
18. Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition. Hoshino K; Kitamura A; Morrissey I; Sato K; Kato J; Ikeda H Antimicrob Agents Chemother; 1994 Nov; 38(11):2623-7. PubMed ID: 7872758 [TBL] [Abstract][Full Text] [Related]
19. Testing potential gyrase inhibitors of bacterial DNA gyrase: a comparison of the supercoiling inhibition assay and "cleavable complex" assay. Barrett JF; Bernstein JI; Krause HM; Hilliard JJ; Ohemeng KA Anal Biochem; 1993 Oct; 214(1):313-7. PubMed ID: 8250240 [TBL] [Abstract][Full Text] [Related]
20. Stereo (C7)-dependent topoisomerase II inhibition and tumor growth suppression by a new quinolone, BO-2367. Yoshinari T; Mano E; Arakawa H; Kurama M; Iguchi T; Nakagawa S; Tanaka N; Okura A Jpn J Cancer Res; 1993 Jul; 84(7):800-6. PubMed ID: 8396568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]